lilly glp 1 injection launches lower-price weight-loss drug without injector pen Eli Lilly touts new weight-loss

A massive effort by chemists at the Eli Lilly pharmaceutical company finally resulted in a viable synthesis, but why this massive effort

If you lost access to semaglutide or tirzepatide, you have options.

That is one of the most overlooked challenges of GLP-1 therapy

Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality

Reduced risk of side effects

Understanding your genetic predispositions and biomarker profile may help inform personalized treatment decisions with your provider